FDA Seeks Public Input on Statistical Design of Rare Disease Clinical Trials

FDA is opening a public docket to gather comments on statistical methods for rare disease clinical investigations ahead of a RISE workshop to inform future guidance. The FDA has established a public docket (2026-18805) to collect comments on statistical considerations for the design of rare...